December 8, 2014
Sosei Group said on December 3 that Ultibro Breezhaler, a fixed-dose combination drug containing indacaterol and glycopyrronium, was launched in the UK for the treatment of chronic obstructive pulmonary disease (COPD). Pfizer Limited rolled out the drug for the COPD...read more